Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Utomilumab by Pfizer for Ovarian Cancer: Likelihood of Approval
Utomilumab is under clinical development by Pfizer and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I...
Utomilumab by Pfizer for Colorectal Cancer: Likelihood of Approval
Utomilumab is under clinical development by Pfizer and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...
Utomilumab by Pfizer for Follicular Lymphoma: Likelihood of Approval
Utomilumab is under clinical development by Pfizer and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase II...